A research team from the Faculty of Medicine at the University of Cologne and the German Centre for Infection Research has achieved a breakthrough: The diagnosis of multi-resistant hospital pathogens is now possible in 45 minutes instead of 72 hours. Further research is necessary before the procedure is ready for clinical application.
The oldest group reported the lowest levels of depressive symptoms and the highest levels of Physical QOL. 'These results were unexpected,' said Dr. Strober, 'given the functional limitations, disease progression, and neurological lesions seen in the aging MS population. Contrary to our hypothesis, the trend by age paralleled the general population. Younger individuals with MS are at greater risk for depression and poor QOL. If confirmed, targeted screening for depression by age may be warranted in this population.'
Researchers have determined that cannabinoid drugs do not appear to reduce the intensity of experimental pain, but, instead, may make pain feel less unpleasant and more tolerable. The paper, whose publication coincides with 'Pain Awareness Month,' represents the first systematic review of experimental research into the effects of cannabis on pain.
An analysis of the NRG Oncology clinical trial NRG-GY003 suggests that adding ipilimumab, a monoclonal antibody that targets the protein receptor CTLA-4, to a regimen with the checkpoint inhibitor nivolumab could improve the proportion with tumor response and progression-free survival hazard rates for women with recurrent epithelial ovarian cancer. These results were presented as a late-breaking abstract oral presentation at the 17th Biennial Meeting of the International Gynecological Cancer Society (IGCS) in Kyoto, Japan.
'These results indicate that processing speed is fundamental to higher order cognitive function in individuals with MS,' said Dr. Chiaravalloti, the Foundation's director of Neuropsychology, Neuroscience, and Traumatic Brain Injury Research. 'Looking at the impact of cognitive interventions on neuropsychological measures isn't enough, however. The outcomes of our research studies need to include the effects of cognitive rehabilitation protocols on how people perform in their daily lives.'
Muscle relaxants are a necessary part of anesthesia during certain major operations. Studies have, however, hinted at respiratory risks connected with these drugs. POPULAR, a major prospective observational European study supported by the European Society of Anaesthesiology (ESA) and led by the Technical University of Munich (TUM), has confirmed the association between use of muscle relaxants and respiratory complications and assessed the chances of the current avoidance strategies.
New four-year study data shows the significant impact of a pioneering contact lens management approach to slowing the progression of myopia (nearsightedness) in children, including those whose treatment begins later. CooperVision is presenting the latest outcomes during the BCLA Asia conference in Singapore this week, at which the globally increasing prevalence of myopia is among the most widely discussed issues.
Taking a low-dose aspirin daily does not prolong healthy living in older adults, according to findings from the ASPirin in Reducing Events in the Elderly (ASPREE) trial published online Sept. 16 in three papers in The New England Journal of Medicine.
First results from a clinical trial of a procedure to open obstructed airways in patients with chronic obstructive pulmonary disease (COPD) have shown that it significantly reduces problems associated with the disease and is safe. Then findings on targeted lung denervation are presented at the European Respiratory Society International Congress.
Prices for drugs under shortage between 2015 and 2016 increased more than twice as quickly as they were expected to in the absence of a shortage. While researchers could not assess reasons for the increases, manufacturers were suspected of exploiting shortages to charge more for drugs in high demand. A brief research report is published in Annals of Internal Medicine.